Knockdown of Son, a mouse homologue of the ZTTK syndrome gene, causes neuronal migration defects and dendritic spine abnormalities.


Journal

Molecular brain
ISSN: 1756-6606
Titre abrégé: Mol Brain
Pays: England
ID NLM: 101468876

Informations de publication

Date de publication:
24 05 2020
Historique:
received: 13 03 2020
accepted: 12 05 2020
entrez: 26 5 2020
pubmed: 26 5 2020
medline: 5 6 2021
Statut: epublish

Résumé

Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, a rare congenital anomaly syndrome characterized by intellectual disability, brain malformation, facial dysmorphism, musculoskeletal abnormalities, and some visceral malformations is caused by de novo heterozygous mutations of the SON gene. The nuclear protein SON is involved in gene transcription and RNA splicing; however, the roles of SON in neural development remain undetermined. We investigated the effects of Son knockdown on neural development in mice and found that Son knockdown in neural progenitors resulted in defective migration during corticogenesis and reduced spine density on mature cortical neurons. The induction of human wild-type SON expression rescued these neural abnormalities, confirming that the abnormalities were caused by SON insufficiency. We also applied truncated SON proteins encoded by disease-associated mutant SON genes for rescue experiments and found that a truncated SON protein encoded by the most prevalent SON mutant found in ZTTK syndrome rescued the neural abnormalities while another much shorter mutant SON protein did not. These data indicate that SON insufficiency causes neuronal migration defects and dendritic spine abnormalities, which seem neuropathological bases of the neural symptoms of ZTTK syndrome. In addition, the results support that the neural abnormalities in ZTTK syndrome are caused by SON haploinsufficiency independent of the types of mutation that results in functional or dysfunctional proteins.

Identifiants

pubmed: 32448361
doi: 10.1186/s13041-020-00622-4
pii: 10.1186/s13041-020-00622-4
pmc: PMC7245844
doi:

Substances chimiques

DNA-Binding Proteins 0
Nuclear Proteins 0
Son protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

80

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP17K16292
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : JP16K10202
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : JP15K06795
Pays : International

Références

Am J Hum Genet. 2016 Sep 1;99(3):711-719
pubmed: 27545680
Wiley Interdiscip Rev RNA. 2014 Sep-Oct;5(5):637-46
pubmed: 24789761
Cereb Cortex. 2000 Oct;10(10):981-91
pubmed: 11007549
Genet Med. 2015 Oct;17(10):774-81
pubmed: 25590979
Mol Genet Genomic Med. 2019 Nov;7(11):e953
pubmed: 31557424
Mol Cell. 2011 Apr 22;42(2):185-98
pubmed: 21504830
J Cell Sci. 2011 Dec 15;124(Pt 24):4286-98
pubmed: 22193954
Genomics. 2000 Aug 15;68(1):57-62
pubmed: 10950926
Nat Cell Biol. 2013 Oct;15(10):1141-1152
pubmed: 24013217
J Biol Chem. 2001 Jun 29;276(26):24059-67
pubmed: 11306577
Curr Opin Neurobiol. 2012 Jun;22(3):530-6
pubmed: 22000839
Am J Med Genet A. 2016 Oct;170(10):2587-90
pubmed: 27256762
Science. 1974 Dec 20;186(4169):1126-8
pubmed: 4469701
J Biol Chem. 2013 Feb 22;288(8):5381-8
pubmed: 23322776
Mutat Res Rev Mutat Res. 2014 Oct-Dec;762:52-64
pubmed: 25485595
Neuroscience. 2001;103(4):865-72
pubmed: 11301197
Am J Hum Genet. 2016 Sep 1;99(3):720-727
pubmed: 27545676
Cell. 2010 Nov 24;143(5):826-36
pubmed: 21111240
Kidney Int. 2019 Jun;95(6):1494-1504
pubmed: 31005274
Mol Cell. 2016 Mar 17;61(6):859-73
pubmed: 26990989
Mol Biol Cell. 2010 Feb 15;21(4):650-63
pubmed: 20053686
Neural Dev. 2013 Nov 13;8:21
pubmed: 24225308
J Cell Sci. 2017 Dec 15;130(24):4180-4192
pubmed: 29133588

Auteurs

Masashi Ueda (M)

Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan.

Tohru Matsuki (T)

Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan.

Masahide Fukada (M)

Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan.

Shima Eda (S)

Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan.

Akie Toya (A)

Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan.
Department of Neurobiochemistry, Nagoya University School of Medicine, Nagoya, Aichi, 4668560, Japan.

Akio Iio (A)

Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan.
Biogate Co. Ltd., 331-1 Ohmori, Yamagata, Gifu, 5012123, Japan.

Hidenori Tabata (H)

Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan.

Atsuo Nakayama (A)

Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, 4800392, Japan. atsuon@inst-hsc.jp.
Department of Neurobiochemistry, Nagoya University School of Medicine, Nagoya, Aichi, 4668560, Japan. atsuon@inst-hsc.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH